Advertisement

Low-Grade Gliomas

  • Anuradha BanerjeeEmail author
  • Theodore Nicolaides
Chapter
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

Astrocytomas are the most common subgroup of central nervous system (CNS) tumors in children. The most frequent histological types are pilocytic and fibrillary astrocytomas, which are considered low-grade astrocytomas. A variety of other, less common glial tumors are also seen in children, including pleomorphic xanthoastrocytoma (PXA), subependymal giant cell astrocytoma, high-grade gliomas, ganglioglioma and desmoplastic infantile ganglioglioma, astroblastoma, ependymoma, and oligodendroglioma. This chapter focuses on low-grade astrocytomas with an emphasis on infiltrating astrocytoma, cerebellar astrocytoma, optic pathway glioma, and oligodendroglioma.

Keywords

Cyst Wall Pilocytic Astrocytoma Gross Total Resection Pediatric Brain Tumor Mural Nodule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aarsen FK, Van Dongen HR, Paquier PF, Van Mourik M, Catsman-Berrevoets CE (2004) Long-term sequelae in children after cerebellar astrocytoma surgery. Neurology 62:1311–1316PubMedCrossRefGoogle Scholar
  2. Abdollahzadeh M, Hoffman HJ, Blazer SI, Becker LE, Humphreys RP, Drake JM, Rutka JT (1994) Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980–1992. Childs Nerv Syst 10:380–383PubMedCrossRefGoogle Scholar
  3. Akyol FH, Atahan IL, Zorlu F, Gurkaynak M, Alanyali H, Ozyar E (1992) Results of post-operative or exclusive radiotherapy in grade I and grade II cerebellar astrocytoma patients. Radiother Oncol 23:245–248PubMedCrossRefGoogle Scholar
  4. Alvord EC Jr, Lofton S (1988) Gliomas of the optic nerve or chiasm. Outcome by patients’ age, tumor site, and treatment. J Neurosurg 68:85–98PubMedCrossRefGoogle Scholar
  5. Anderson JL, Gutmann DH (2015) Neurofibromatosis type 1. Handb Clin Neurol 132:75–86PubMedCrossRefGoogle Scholar
  6. Apuzzo MLJ, Litofsky NS (1993) Surgery in and around the anterior third ventricle. In: Apuzzo MLJ (ed) Brain surgery: complication avoidance and management, vol 1. Churchill Livingstone, New York, p 541Google Scholar
  7. Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff JH, Pollack IF (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. J Clin Oncol 30:2641–2647PubMedPubMedCentralCrossRefGoogle Scholar
  8. Awdeh RM, Kiehna EN, Drewry RD, Kerr NC, Haik BG, Wu S, Xiong X, Merchant TE (2012) Visual outcomes in pediatric optic pathway glioma after conformal radiation therapy. Int J Radiat Oncol Biol Phys 84:46–51PubMedPubMedCentralCrossRefGoogle Scholar
  9. Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE (2014) Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61:1173–1179PubMedPubMedCentralCrossRefGoogle Scholar
  10. Banerjee A, Jakacki R, Onar-Thomas A, Wu S, Nicolaides T, Turner D, Richardson S, Young-Poussaint T, Phillips J, Prados M, Packer R, Qaddoumi I, Gururangan S, Goldman S, Pollack I, Doyle LA, Stewart C, Boyett J, Fouladi M (2014) A phase 1 study of AZD6244 in children with recurren or refractory low-grade gliomas: a Pediatric Brain Tumor Consortium Report. J Clin Oncol 32:5s, suppl: abstr 10064CrossRefGoogle Scholar
  11. Baram TZ, Moser RP, Van Eyes J (1986) Surgical management of progressive visual loss in optic gliomas of childhood. Ann Neurol 20:398Google Scholar
  12. Bataini JP, Delanian S, Ponvert D (1991) Chiasmal gliomas: results of irradiation management in 57 patients and review of literature. Int J Radiat Oncol Biol Phys 21:615–623PubMedCrossRefGoogle Scholar
  13. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923–929PubMedCrossRefGoogle Scholar
  14. Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH (2005) Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204PubMedCrossRefGoogle Scholar
  15. Benesch M, Eder HG, Sovinz P, Raith J, Lackner H, Moser A, Urban C (2006) Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003. Pediatr Neurosurg 42:159–164PubMedCrossRefGoogle Scholar
  16. Berger MS (1996) Chapter 119: cerebellar astrocytoma. In: Becker DP, Dunsker SB, Friedman WA, Hoffman HJ, Smith RR, Wilson CB (eds) Tumors, vol 4. Saunders, Philadelphia, pp 2593–2602Google Scholar
  17. Berger MS, Ghatan S, Geyer JR, Keles GE, Ojemann GA (1991) Seizure outcome in children with hemispheric tumors and associated intractable epilepsy: the role of tumor removal combined with seizure foci resection. Pediatr Neurosurg 17:185–191PubMedCrossRefGoogle Scholar
  18. Berger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA (1993) Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg 79:62–69PubMedCrossRefGoogle Scholar
  19. Bigner SH, McLendon RE, Fuchs H, McKeever PE, Friedman HS (1997) Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet 97:125–134PubMedCrossRefGoogle Scholar
  20. Boch AL, Cacciola F, Mokhtari K, Kujas M, Philippon J (2000) Benign recurrence of a cerebellar pilocytic astrocytoma 45 years after gross total resection. Acta Neurochir 142:341–346PubMedCrossRefGoogle Scholar
  21. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q (2001) Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553–1557PubMedCrossRefGoogle Scholar
  22. Bonfield CM, Steinbok P (2015) Pediatric cerebellar astrocytoma: a review. Childs Nerv Syst 31:1677–1685PubMedCrossRefGoogle Scholar
  23. Borit A, Richardson EP Jr (1982) The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain 105:161–187PubMedCrossRefGoogle Scholar
  24. Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 30:1358–1363PubMedCrossRefGoogle Scholar
  25. Burger PC, Scheitauer BW, Paulus W, Szymas J, Gianni C, Kleihues P (2000) Chapter 1: pilocytic astrocytoma. In: Cavenee PKW (ed) Tumors of the nervous system: pathology & genetics. IARC, LyonGoogle Scholar
  26. Bynke H, Kagstrom E, Tjernstrom K (1977) Aspects on the treatment of gliomas of the anterior visual pathway. Acta Ophthalmol (Copenh) 55:269–280CrossRefGoogle Scholar
  27. Cairncross JG, Laperriere NJ (1989) Low-grade glioma. To treat or not to treat? Arch Neurol 46:1238–1239PubMedCrossRefGoogle Scholar
  28. Campbell JW, Pollack IF (1996) Cerebellar astrocytomas in children. J Neuro-Oncol 28:223–231CrossRefGoogle Scholar
  29. Castello MA, Schiavetti A, Varrasso G, Clerico A, Cappelli C (1998) Chemotherapy in low-grade astrocytoma management. Childs Nerv Syst 14:6–9PubMedCrossRefGoogle Scholar
  30. Chadderton RD, West CG, Schuller S, Quirke DC, Gattamaneni R, Taylor R, Schulz S (1995) Radiotherapy in the treatment of low-grade astrocytomas. II. The physical and cognitive sequelae. Childs Nerv Syst 11:443–448PubMedCrossRefGoogle Scholar
  31. Chamberlain MC (1997) Recurrent cerebellar gliomas: salvage therapy with oral etoposide. J Child Neurol 12:200–204PubMedCrossRefGoogle Scholar
  32. Chamdine O, Broniscer A, Wu S, Gajjar A, Qaddoumi I (2016) Metastatic low-grade gliomas in children: 20 years’ experience at St. Jude Children’s Research Hospital. Pediatric Blood and Cancer 63:62–70PubMedCrossRefGoogle Scholar
  33. Chen, Guttman (2014) The molecular and cell biology of pediatric low-grade gliomas. Oncogene 33:2019–2026PubMedCrossRefGoogle Scholar
  34. Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS (1999) Genetic alterations in pediatric high-grade astrocytomas. Hum Pathol 30:1284–1290PubMedCrossRefGoogle Scholar
  35. Chong A, Bouffet E, Huang A, Bartels U (2008) Optic path-way gliomas in adolescence. In: The 13th international symposium on pediatric neuro-oncology. Society for Neuro-Oncology, Chicago, p 449Google Scholar
  36. Combs SE, Schulz-Ertner D, Moschos D, Thilmann C, Huber PE, Debus J (2005) Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 62:814–819PubMedCrossRefGoogle Scholar
  37. Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657–668PubMedCrossRefGoogle Scholar
  38. Dasgupta B, Yi Y, Chen D, Weber J, Gutmann D (2005) Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated and mouse brain tumors. Cancer Res 65:2755–2760PubMedCrossRefGoogle Scholar
  39. Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152–2165PubMedCrossRefGoogle Scholar
  40. Deliganis AV, Geyer JR, Berger MS (1996) Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 38:1114–1118; discussion 1118–1119PubMedGoogle Scholar
  41. Di Pinto M, Conklin HM, Li C, Merchant TE (2012) Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 84:e363–e369PubMedPubMedCentralCrossRefGoogle Scholar
  42. Dirks PB, Jay V, Becker LE, Drake JM, Humphreys RP, Hoffman HJ, Rutka JT (1994) Development of anaplastic changes in lowgrade astrocytomas of childhood. Neurosurgery 34:68–78PubMedCrossRefGoogle Scholar
  43. Dirven CM, Mooij JJ, Molenaar WM (1997) Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst 13:17–23PubMedCrossRefGoogle Scholar
  44. Dohrmann GJ, Farwell JR, Flannery JT (1985) Astrocytomas in childhood: a population-based study. Surg Neurol 23:64–68PubMedCrossRefGoogle Scholar
  45. Dropcho EJ, Wisoff JH, Walker RW, Allen JC (1987) Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 22:355–364PubMedCrossRefGoogle Scholar
  46. Edwards MS, Levin VA, Wilson CB (1980) Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat Rep 64:1179–1205PubMedGoogle Scholar
  47. Ellenberg L, McComb JG, Siegel SE, Stowe S (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21:638–644PubMedCrossRefGoogle Scholar
  48. Farwell JR, Dohrmann GJ, Flannery JT (1977) Central nervous system tumors in children. Cancer 40:3123–3132PubMedCrossRefGoogle Scholar
  49. Felix CA, Slavc I, Dunn M, Strauss EA, Phillips PC, Rorke LB, Sutton L, Bunin GR, Biegel JA (1995) p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol 25:431–436PubMedCrossRefGoogle Scholar
  50. Flickinger JC, Torres C, Deutsch M (1988) Management of low-grade gliomas of the optic nerve and chiasm. Cancer 61:635–642PubMedCrossRefGoogle Scholar
  51. Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL (2003) Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children’s Cancer Group high-grade glioma study CCG-945. Cancer 98:1243–1252Google Scholar
  52. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59:490–498PubMedCrossRefGoogle Scholar
  53. Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Anak O, Niolat J, Jozwiak S (2014) Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol 15:1513–1520PubMedCrossRefGoogle Scholar
  54. Freeman CR, Farmer JP, Montes J (1998) Low-grade astrocytomas in children: evolving management strategies. Int J Radiat Oncol Biol Phys 41:979–987PubMedCrossRefGoogle Scholar
  55. Gajjar A, Heideman RL, Kovnar EH, Langston JA, Sanford RA, Douglass EC, Jenkins JJ, Horowitz ME, Kun LE (1993) Response of pediatric low grade gliomas to chemotherapy. Pediatr Neurosurg 19:113–118; discussion 119–120PubMedCrossRefGoogle Scholar
  56. Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, Walter AW, Kuttesch JF, Muhlbauer M, Kun LE (1995) Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 83:67–71PubMedCrossRefGoogle Scholar
  57. Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, Langston JW, Muhlbauer M, Boyett JM, Kun LE (1997) Low-grade astrocytoma: a decade of experience at St Jude Children’s Research Hospital. J Clin Oncol 15:2792–2799PubMedGoogle Scholar
  58. Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG (2015) Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape. J Clin Oncol 33:2986–2998Google Scholar
  59. Garcia DM, Marks JE, Latifi HR, Kliefoth AB (1990) Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? Int J Radiat Oncol Biol Phys 18:815–818PubMedCrossRefGoogle Scholar
  60. Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, Forsyth PA, Hayostek CJ (1999) Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropatholol Exp Neurol 58:46–53CrossRefGoogle Scholar
  61. Gilles FH, Sobel EL, Tavare CJ, Leviton A, Hedley-Whyte ET (1995) Age-related changes in diagnoses, histological eatures, and survival in children with brain tumors: 1930–1979. The childhood brain tumor consortium. Neurosurgery 37:1056–1068PubMedCrossRefGoogle Scholar
  62. Gjerris F, Agerlin N, Borgesen SE, Buhl L, Haase J, Klinken L, Mortensen AC, Olsen JH, Ovesen N, Reske-Nielsen E, Schmidt K (1998) Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960–1984. Childs Nerv Syst 14:302–311PubMedCrossRefGoogle Scholar
  63. Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol 14:1265–1284PubMedPubMedCentralCrossRefGoogle Scholar
  64. Gold EB, Leviton A, Lopez R, Gilles FH, Hedley-Whyte ET, Kolonel LN, Lyon JL, Swanson GM, Weiss NS, West D et al (1993) Parental smoking and risk of childhood brain tumors. Am J Epidemiol 137:620–628PubMedGoogle Scholar
  65. Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C (2014) The role of surgery in optic pathway/hypothalamic gliomas in children. J Neurosurg Pediatr 13:1–12PubMedCrossRefGoogle Scholar
  66. Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, Huang MS, Marcus KJ, Oberg JA, Tarbell NJ, Yock TI (2014) Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys 89:1060–1068PubMedCrossRefGoogle Scholar
  67. Griffin CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BS (1988) Chromosome abnormalities in pediatric brain tumors. Cancer Res 48:175–180PubMedGoogle Scholar
  68. Guertin D, Sabatini D (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22PubMedCrossRefGoogle Scholar
  69. Gunny RS, Hayward RD, Phipps KP, Harding BN, Saunders DE (2005) Spontaneous regression of residual low-grade cerebellar pilocytic astrocytomas in children. Pediatr Radiol 35:1086–1091PubMedCrossRefGoogle Scholar
  70. Gururangan S, Cavazos CM, Ashley D, Herndon JE 2nd, Bruggers CS, Moghrabi A, Scarcella DL, Watral M, Tourt-Uhlig S, Reardon D, Friedman HS (2002) Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 20:2951–2958PubMedCrossRefGoogle Scholar
  71. Gururangan S, Fisher MJ, Allen JC, Herndon JE 2nd, Quinn JA, Reardon DA, Vredenburgh JJ, Desjardins A, Phillips PC, Watral MA, Krauser JM, Friedman AH, Friedman HS (2007) Temozolomide in children with progressive lowgrade glioma. Neuro Oncol 9:161–168PubMedPubMedCentralCrossRefGoogle Scholar
  72. Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Fouladi M, Kun LE (2014) Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas-a Pediatric Brain Tumor Consortium study. Neuro Oncol 16:310–317PubMedCrossRefGoogle Scholar
  73. Gutmann DH, Donahoe J, Brown T, James CD, Perry A (2000) Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol 26:361–367PubMedCrossRefGoogle Scholar
  74. Hadjipanayis CG, Kondziolka D, Flickinger JC, Lunsford LD (2003) The role of stereotactic radiosurgery for low-grade astrocytomas. Neurosurg Focus 14:e15PubMedCrossRefGoogle Scholar
  75. Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA (1992) Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with lowgrade gliomas. J Neurosurg 77:209–216PubMedCrossRefGoogle Scholar
  76. Halperin E, Constine L, Tarbell N, Kun L (1999) Pediatric radiation oncology. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  77. Hayostek CJ, Shaw EG, Scheithauer B, O’Fallon JR, Weiland TL, Schomberg PJ, Kelly PJ, Hu TC (1993) Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 72:856–869PubMedCrossRefGoogle Scholar
  78. Herfarth KK, Gutwein S, Debus J (2001) Postoperative radiotherapy of astrocytomas. Semin Surg Oncol 20:13–23PubMedCrossRefGoogle Scholar
  79. Hoffman H, Rutka J (1999) Optic pathway gliomas in children. In: Albright L, Pollack I, Adelson D (eds) Principles and practice of pediatric neurosurgery. Thieme, New York, pp 535–543Google Scholar
  80. Horwich A, Bloom HJ (1985) Optic gliomas: radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 11:1067–1079PubMedCrossRefGoogle Scholar
  81. Houghton PJ, Huang S (2004) mTOR as a target for cancer therapy. Curr Top Microbiol Immunol 279:339–359PubMedGoogle Scholar
  82. Housepian E (1977) Management and results in 114 cases of optic glioma. Neurosurgery 1:67–68Google Scholar
  83. Housepian E (1993) Complications of transcranial orbital surgery. In: Post K, Friedman E, McCormick P (eds) Postoperative complications in intracranial neurosurgery. Thieme, New York, pp 87–90Google Scholar
  84. Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS Jr (1998) Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19:535–540PubMedGoogle Scholar
  85. Imes RK, Hoyt WF (1986) Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study. Br J Ophthalmol 70:179–182PubMedPubMedCentralCrossRefGoogle Scholar
  86. Imielinski BL, Kloc W, Wasilewski W, Liczbik W, Puzyrewski R, Karwacki Z (1998) Posterior fossa tumors in children – indications for ventricular drainage and for V-P shunting. Childs Nerv Syst 14:227–229PubMedCrossRefGoogle Scholar
  87. Ishii N, Sawamura Y, Tada M, Daub DM, Janzer RC, Meagher-Villemure M, de Tribolet N, Van Meir EG (1998) Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay. Int J Cancer 76:797–800PubMedCrossRefGoogle Scholar
  88. Ito S, Hoshino T, Shibuya M, Prados MD, Edwards MS, Davis RL (1992) Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling. Neurosurgery 31:413–418; discussion 419PubMedCrossRefGoogle Scholar
  89. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT et al (1995) Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051–1059PubMedCrossRefGoogle Scholar
  90. Jenkin D, Angyalfi S, Becker L et al (1993) Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 25:215–225PubMedCrossRefGoogle Scholar
  91. Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, Harter DH, Goldberg JD, Hochman T, Merkelson A, Bloom MC, Sievert AJ, Resnick AC, Dhall G, Jones DT, Korshunov A, Pfister SM, Eberhart CG, Zagzag D, Allen JC (2014) Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol 16:1408–1416PubMedPubMedCentralCrossRefGoogle Scholar
  92. Karnes PS, Tran TN, Cui MY, Raffel C, Gilles FH, Barranger JA, Ying KL (1992) Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 59:12–19PubMedCrossRefGoogle Scholar
  93. Kaye AH, Walker DG (2000) Low grade astrocytomas: controversies in management. J Clin Neurosci 7:475–483PubMedCrossRefGoogle Scholar
  94. Keiran M, Yao X, Macy M, Leary S, Cohen K, MacDonald T, Allen J, Boklan J, Smith A, Nazemi K, Gore T, Trippett J, DiRenzo J, Narendran A, Perentesis J, Prabhu S, Pinches N, Robison N, Manley P, Chi S (2014) Final results of a prospective multi-institutional phase II study of everolimus (RAD001), an mTOR inhibitor, in pediatric patients with recurrent of progressive low –grade glioma, A POETIC consortium trial. Neuro Oncol 16(suppl3):iii–27Google Scholar
  95. Keles G, Berger M (2000) Seizures associated with brain tumors. In: Bernstein M, Berger M (eds) Neuro-oncology essentials. Thieme, New York, pp 473–477Google Scholar
  96. Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–745PubMedCrossRefGoogle Scholar
  97. Kepes JJ, Kepes M, Slowik F (1973) Fibrous xanthomas and xanthosarcomas of the meninges and the brain. Acta Neuropathol 23:187–199PubMedCrossRefGoogle Scholar
  98. Kieran MW, Hargrave DR, Cohen KJ, Aerts I, Dunkel IJ, Hummel TR, Jimenez I, Pearson ADJ, Pratilas CA, Whitlock J, Bouffet E, Shen WPV, Broniscer A, Bertozzi AI, Sandberg JL, Florance AM, Suttle BB, Haney P, Russo MW, Geoerger B (2015) Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (LCH), and other solid tumors (OST). J Clin Oncol 32:5s, suppl; abstr 10056Google Scholar
  99. Kim AH, Thompson EA, Governale LS, Santa C, Cahll K, Kieran MW, Chi SN, Ullrich NJ, Scott RM, Goumnerova LC (2014) Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging. J Pediatr Neurosurg 14:356–364CrossRefGoogle Scholar
  100. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268PubMedCrossRefGoogle Scholar
  101. Kordes U, Von Hornstein S, Thieme B, Breitmoser-Greiner S, Gnekow A (2008) Second chemotherapy for relapsed pediatric low-grade glioma: the HIT-LGG 96 experience. In: The 13th international symposium on pediatric neuro-oncology. Society for Neuro-Oncology, Chicago, p 452Google Scholar
  102. Kosel S, Scheithauer BW, Graeber MB (2001) Genotype-phenotype correlation in gemistocytic astrocytomas. Neurosurgery 48:187–193PubMedCrossRefGoogle Scholar
  103. Kovalic JJ, Grigsby PW, Shepard MJ, Fineberg BB, Thomas PR (1990) Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 18:927–932PubMedCrossRefGoogle Scholar
  104. Krieger MD, Gonzalez-Gomez I, Levy ML, McComb JG (1997) Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 27:1–11PubMedCrossRefGoogle Scholar
  105. Kyritsis AP, Bondy ML, Rao JS, Sioka C (2010) Inherited predisposition to glioma. Neuro Oncol 12:104–113PubMedCrossRefGoogle Scholar
  106. Lapras C, Palet J, Lapras C Jr, Mottolese C (1986) Cerebellar astrocytomas in the childhood. Childs Nerv Syst 2:55–59PubMedCrossRefGoogle Scholar
  107. Lassaletta A, Bouffet E, Mabbott D, Kulkarni AV (2015) Functional and neuropsychological late outcomes in posterior fossa tumors in children. Childs Nerv Syst 31:1877–1890PubMedCrossRefGoogle Scholar
  108. Lazareff JA, Bockhorst KH, Curran J, Olmstead C, Alger JR (1998) Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 43:809–817; discussion 817–808PubMedCrossRefGoogle Scholar
  109. Lewis R, Gerson L, Axelson K et al (1984) von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata. Ophthalmology 91:929–935PubMedCrossRefGoogle Scholar
  110. Li J, Perry A, James CD, Gutmann DH (2001) Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 56:885–890PubMedCrossRefGoogle Scholar
  111. Lindboe CF, Cappelen J, Kepes JJ (1992) Pleomorphic xanthoastrocytoma as a component of a cerebellar ganglioglioma: case report. Neurosurgery 31:353–355PubMedCrossRefGoogle Scholar
  112. Listernick R, Charrow J, Gutmann DH (1999) Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89:38–44PubMedCrossRefGoogle Scholar
  113. Litofsky NS, Hinton D, Raffel C (1994) The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 34:967–972PubMedCrossRefGoogle Scholar
  114. Lote K, Egeland T, Hager B, Skullerud K, Hirschberg H (1998) Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma. J Neuro-Oncol 40:161–170CrossRefGoogle Scholar
  115. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumors of the central nervous system. International Agency for Research on Cancer, LyonGoogle Scholar
  116. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P, International Society Of Neuropathology – Haarlem (2014) International Society Of Neuropathology – Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435PubMedCrossRefGoogle Scholar
  117. Magli A, Forte R, Cinalli G, Esposito F, Parisi S, Capasso M, Papparella A (2013) Functional changes after treatment of optic pathway paediatric low-grade gliomas. Eye 27:1288–1292PubMedPubMedCentralCrossRefGoogle Scholar
  118. Mamelak AN, Prados MD, Obana WG, Cogen PH, Edwards MS (1994) Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg 81:24–30PubMedCrossRefGoogle Scholar
  119. Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ (2005) Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 61:374–379PubMedCrossRefGoogle Scholar
  120. Maroon JC, Kennerdel JS (1976) Lateral microsurgical approach to intraorbital tumors. J Neurosurg 44:556–561PubMedCrossRefGoogle Scholar
  121. McCowage G, Tien R, McLendon R, Felsberg G, Fuchs H, Graham ML, Kurtzberg J, Moghrabi A, Ferrell L, Kerby T, Duncan-Brown M, Stewart E, Robertson PL, Colvin OM, Golembe B, Bigner DD, Friedman HS (1996) Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol 27:32–39PubMedCrossRefGoogle Scholar
  122. Merchant TE, Kun LE, Wu S, Xiong X, Sanford RA, Boop FA (2009a) Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol 27:3598–3604PubMedPubMedCentralCrossRefGoogle Scholar
  123. Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X (2009b) Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27:3691–3697PubMedPubMedCentralCrossRefGoogle Scholar
  124. Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA (2010) Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neuro-Oncol 100:121–127CrossRefGoogle Scholar
  125. Morikawa M, Tamaki N, Kokunai T, Nagashima T, Kurata H, Yamamoto K, Imai Y, Itoh H (1997) Cerebellar pilocytic astrocytoma with leptomeningeal dissemination: case report. Surg Neurol 48:49–51PubMedCrossRefGoogle Scholar
  126. Morreale VM, Ebersold MJ, Quast LM, Parisi JE (1997) Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. J Neurosurg 87:257–261PubMedCrossRefGoogle Scholar
  127. Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K (1993) Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71:40–49PubMedCrossRefGoogle Scholar
  128. Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E (2009) Natural history and outcome of optic pathway gliomas in children. Pediatric Blood and Cancer 53:1231–1237PubMedCrossRefGoogle Scholar
  129. Oakes W (1990) Recent experience with the resection of pilocytic astrocytomas of the hypothalamus. In: Marlin A (ed) Concepts in pediatric neurosurgery, vol 10. Karger, Basel, p 108Google Scholar
  130. Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS (2015) Alex’s Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011. Neuro-Oncology 16(Suppl 10):iv1–iv62Google Scholar
  131. Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, Chen J (2014) Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst 30:561–570PubMedCrossRefGoogle Scholar
  132. Oxenhandler DC, Sayers MP (1978) The dilemma of childhood optic gliomas. J Neurosurg 48:34–41PubMedCrossRefGoogle Scholar
  133. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L (1988) Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 23:79–85PubMedCrossRefGoogle Scholar
  134. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN et al (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850–856PubMedGoogle Scholar
  135. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive lowgrade gliomas. J Neurosurg 86:747–754PubMedCrossRefGoogle Scholar
  136. Packer R, Vezina G, Nicholson H, Chadduck W (1999) Child-hood and adolescent gliomas. In: Albright L, Pollack I, Adelson D (eds) Principles and practice of pediatric neurosurgery. Thieme, New York, pp 689–701Google Scholar
  137. Palma L, Celli P, Mariottini A (2004) Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumour regression. Acta Neurochir 146:581–588PubMedCrossRefGoogle Scholar
  138. Paulino AC, Mazloom A, Terashima K, Su J, Adesina AM, Okcu MF, Teh BS, Chintagumpala M (2013) Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer 119:2654–2659PubMedCrossRefGoogle Scholar
  139. Pencalet P, Maixner W, Sainte-Rose C, Lellouch-Tubiana A, Cinalli G, Zerah M, Pierre-Kahn A, Hoppe-Hirsch E, Bourgeois M, Renier D (1999) Benign cerebellar astrocytomas in children. J Neurosurg 90:265–273PubMedCrossRefGoogle Scholar
  140. Peraud A, Grau S, Tonn J, Kreth F (2008) Treatment concepts for pediatric low grade gliomas in critical locations. In: The 13th international symposium on pediatric neuro-oncology. Society for Neuro-Oncology, Chicago, pp 473–474Google Scholar
  141. Pfister S, Janzarik W, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Investig 118:1739–1749PubMedPubMedCentralCrossRefGoogle Scholar
  142. Pierce SM, Barnes PD, Loeffler JS, McGinn C, Tarbell NJ (1990) Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer 65:45–52PubMedCrossRefGoogle Scholar
  143. Pollack IF (1999) Pediatric brain tumors. Semin Surg Oncol 16:73–90PubMedCrossRefGoogle Scholar
  144. Pollack IF, Hurtt M, Pang D, Albright AL (1994) Dissemination of low grade intracranial astrocytomas in children. Cancer 73:2869–2878PubMedCrossRefGoogle Scholar
  145. Pollack IF, Claassen D, Al-Shboul Q, Janosky JE, Deutsch M (1995) Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 82:536–547PubMedCrossRefGoogle Scholar
  146. Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA (1996) Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 20:80–85PubMedCrossRefGoogle Scholar
  147. Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA (1997) Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-Oncol 32:235–241CrossRefGoogle Scholar
  148. Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Modan B, Holly EA, Filippini G, Cordier S, Peris-Bonet R, Choi W, Little J, Arslan A (1998) Prenatal vitamin supplementation and pediatric brain tumors: huge international variation in use and possible reduction in risk. Childs Nerv Syst 14:551–557PubMedCrossRefGoogle Scholar
  149. Rashidi M, Reis DaSilva V, Minagar A, Rutka J (2003) Nonmalignant pediatric brain tumors. Curr Neurol Neurosci Rep 3:200–205PubMedCrossRefGoogle Scholar
  150. Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31:431–436PubMedCrossRefGoogle Scholar
  151. Reddy ATM, Timothy B (2000) Chapter 74: cerebellar astrocytoma. In: McLone DG (ed) Pediatric neurosurgery: surgery of the developing nervous system, 4th edn. Saunders, New York, pp 835–843Google Scholar
  152. Riccardi V (1992) Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr 22:66–106PubMedGoogle Scholar
  153. Rickert CH (1998) Epidemiological features of brain tumors in the first 3 years of life. Childs Nerv Syst 14:547–550PubMedCrossRefGoogle Scholar
  154. Rickert CH, Paulus W (2001) Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 17:503–511PubMedCrossRefGoogle Scholar
  155. Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMedGoogle Scholar
  156. Roberts P, Chumas PD, Picton S, Bridges L, Livingstone JH, Sheridan E (2001) A review of the cytogenetics of 58 pediatric brain tumors. Cancer Genet Cytogenet 131:1–12PubMedCrossRefGoogle Scholar
  157. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039PubMedCrossRefGoogle Scholar
  158. Rosenfeld JV (2000) Chapter 37: cerebellar astrocytoma in children. In: Kaye AH, Black PM (eds) Operative neurosurgery, vol 2. Churchill Livingstone, New York, pp 447–463Google Scholar
  159. Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Maarouf M, Treuer H, Berthold F, Sturm V, Voges J (2011) Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol 29:2151–2159Google Scholar
  160. Ruggieri M (1999) The different forms of neurofibromatosis. Childs Nerv Syst 15:295–308PubMedCrossRefGoogle Scholar
  161. Rush JA, Younge BR, Campbell RJ, MacCarty CS (1982) Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 89:1213–1219PubMedCrossRefGoogle Scholar
  162. Rutka J, Hoffman H, Duncan J (1996) Astrocytomas of the posterior fossa. Blackwell Science, CambridgeGoogle Scholar
  163. Sabatini D (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6:729–734PubMedCrossRefGoogle Scholar
  164. Sainte-Rose C, Cinalli G, Roux FE, Maixner R, Chumas PD, Mansour M, Carpentier A, Bourgeois M, Zerah M, Pierre-Kahn A, Renier D (2001) Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. J Neurosurg 95:791–797PubMedCrossRefGoogle Scholar
  165. Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F, Arifin MT, Arita K, Kurisu K (2006) Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Anticancer Res 26:1351–1357PubMedGoogle Scholar
  166. Schneider JH Jr, Raffel C, McComb JG (1992) Benign cerebellar astrocytomas of childhood. Neurosurgery 30:58–62PubMedCrossRefGoogle Scholar
  167. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947–949PubMedCrossRefGoogle Scholar
  168. Sener R (2002) Diffusion MRI in neurofibromatosis type 1: ADC evaluations of the optic pathways, and a comparison with normal individuals. Comput Med Imaging Graph 26:59–64PubMedCrossRefGoogle Scholar
  169. Sgouros S, Fineron PW, Hockley AD (1995) Cerebellar astrocytoma of childhood: long-term follow-up. Childs Nerv Syst 11:89–96PubMedCrossRefGoogle Scholar
  170. Shafqat S, Hedley-Whyte ET, Henson JW (1999) Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neurology 52:867–869PubMedCrossRefGoogle Scholar
  171. Sharma M, Zehnbauer B, Watson M, Gutmann D (2005) RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma. Neurology 65:1335–1336PubMedCrossRefGoogle Scholar
  172. Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neurooncology 5:153–160Google Scholar
  173. Sievert AJ, Fisher MJ (2009) Pediatric low-grade gliomas. J Child Neurol 24:1397–1408PubMedPubMedCentralCrossRefGoogle Scholar
  174. Sievert A, Jackson E, Gai X, Hakonarson H, Judkins A, Resnick A, Shaikh T, Biegel J (2008) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density SNP-based genotyping. In: The 13th international symposium on pediatric neuro-oncology. Society for Neuro-Oncology, Chicago, p 379Google Scholar
  175. Sievert AJ, Lang SS, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC (2013) Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proc Natl Acad Sci 10:5957–5962CrossRefGoogle Scholar
  176. Smoots DW, Geyer JR, Lieberman DM, Berger MS (1998) Predicting disease progression in childhood cerebellar astrocytoma. Childs Nerv Syst 14:636–648PubMedCrossRefGoogle Scholar
  177. Somaza SC, Kondziolka D, Lunsford LD, Flickinger JC, Bissonette DJ, Albright AL (1996) Early outcomes after stereotactic radiosurgery for growing pilocytic astrocytomas in children. Pediatr Neurosurg 25:109–115PubMedCrossRefGoogle Scholar
  178. Steinbok P, Mutat A (1999) Chapter 35: cerebellar astrocytoma. In: Albright AL, Pollack IF, Adelson PD (eds) Principles and practice of pediatric neurosurgery. Thieme, New York, p xxiii; 1300Google Scholar
  179. Steinbok P, Hentschel S, Cochrane DD, Kestle JR (1996) Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84:726–732PubMedCrossRefGoogle Scholar
  180. Steinbok P, Poskitt K, Hendson G (2006) Spontaneous regression of cerebellar astrocytoma after subtotal resection. Childs Nerv Syst 22:572–576PubMedCrossRefGoogle Scholar
  181. Steinbok P, Mangat JS, Kerr JM, Sargent M, Suryaningtyas W, Singhal A, Cochrane D (2013) Neurological morbidity of surgical resection of pediatric cerebellar astrocytomas. Childs Nerv Syst 29:1269–1275PubMedCrossRefGoogle Scholar
  182. Sutton LN, Cnaan A, Klatt L, Zhao H, Zimmerman R, Needle M, Molloy P, Phillips P (1996) Postoperative surveillance imaging in children with cerebellar astrocytomas. J Neurosurg 84:721–725PubMedCrossRefGoogle Scholar
  183. Tamura M, Zama A, Kurihara H, Fujimaki H, Imai H, Kano T, Saitoh F (1998) Management of recurrent pilocytic astrocytoma with leptomeningeal dissemination in childhood. Childs Nerv Syst 14:617–622PubMedCrossRefGoogle Scholar
  184. Tao ML, Barnes PD, Billett AL, Leong T, Shrieve DC, Scott RM, Tarbell NJ (1997) Childhood optic chiasm gliomas: radiographic response following radiotherapy and longterm clinical outcome. Int J Radiat Oncol Biol Phys 39:579–587PubMedCrossRefGoogle Scholar
  185. Taratuto AL, Monges J, Lylyk P, Leiguarda R (1984) Superficial cerebral astrocytoma attached to dura. Report of six cases in infants. Cancer 54:2505–2512PubMedCrossRefGoogle Scholar
  186. Taveras JM, Mount LA, Wood EH (1956) The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 66:518–528PubMedCrossRefGoogle Scholar
  187. Tenny R, Laws E Jr, Younge B et al (1982) The neurosurgical management of optic glioma: results in 104 Patients. J Neurosurg 57:452–458PubMedCrossRefGoogle Scholar
  188. Tsui K, Gajjar A, Li C, Srivastava D, Broniscer A, Wetmore C, Kun LE, Merchant TE, Ellison DW, Orr BA, Boop FA, Klimo P, Ross J, Robison LL, Armstrong GT (2015) Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro Oncol 17:448–456PubMedGoogle Scholar
  189. Viano JC, Herrera EJ, Suarez JC (2001) Cerebellar astrocytomas: a 24-year experience. Childs Nerv Syst 17:607–610; discussion 611PubMedCrossRefGoogle Scholar
  190. Vienneau D, Infanger D, Feychting M, Schüz J, Schmidt LS, Poulsen AH, Tettamanti G, Klæboe L, Kuehni CE, Tynes T, Von der Weid N, Lannering B, Röösli M (2015) A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: a validation of interview data. Cancer Epidemiol 40:52–59PubMedCrossRefGoogle Scholar
  191. Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P (2000) Cerebellar gliomas in children with NF1: pathology and surgery. Childs Nerv Syst 16:417–420PubMedCrossRefGoogle Scholar
  192. von Hornstein S, Kortmann RD, Pietsch T, Emser A, Warmuth-Metz M, Soerensen N, Straeter R, Graf N, Thieme B, Gnekow AK (2011) Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial. Pediatr Blood Cancer 56:1046–1054CrossRefGoogle Scholar
  193. Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 16:1821–1833PubMedGoogle Scholar
  194. Warren KE, Frank JA, Black JL, Hill RS, Duyn JH, Aikin AA, Lewis BK, Adamson PC, Balis FM (2000) Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol 18:1020–1026PubMedGoogle Scholar
  195. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H (1998) p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol 95:559–564PubMedCrossRefGoogle Scholar
  196. Wernicke C, Thiel G, Lozanova T, Vogel S, Witkowski R (1997) Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics. Genes Chromosomes Cancer 19:6–13PubMedCrossRefGoogle Scholar
  197. White FV, Anthony DC, Yunis EJ, Tarbell NJ, Scott RM, Schofield DE (1995) Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. Hum Pathol 26:979–986PubMedCrossRefGoogle Scholar
  198. White JB, Piepgras DG, Scheithauer BW, Parisi JE (2008) Rate of spontaneous hemorrhage in histologically proven cases of pilocytic astrocytoma. J Neurosurg 108:223–226PubMedCrossRefGoogle Scholar
  199. Wisoff JH, Abbott R, Epstein F (1990) Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73:661–667PubMedCrossRefGoogle Scholar
  200. Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N, Kuhl J (2002) Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94:264–271PubMedCrossRefGoogle Scholar
  201. Wong JY, Uhl V, Wara WM, Sheline GE (1987) Optic gliomas. A reanalysis of the University of California, San Francisco experience. Cancer 60:1847–1855PubMedCrossRefGoogle Scholar
  202. Yalon M, Rood B, MacDonald TJ, McCowage G, Kane R, Constantini S, Packer RJ (2013) A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). Pediatric Blood and Cancer 60:71–76PubMedCrossRefGoogle Scholar
  203. Zattara-Cannoni H, Gambarelli D, Lena G, Dufour H, Choux M, Grisoli F, Vagner-Capodano AM (1998) Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. Cancer Genet Cytogenet 104:157–160PubMedCrossRefGoogle Scholar
  204. Zuzak TJ, Poretti A, Drexel B, Zehnder D, Boltshauser E, Grotzer MA (2008) Outcome of children with low-grade cerebellar astrocytoma: long-term complications and quality of life. Childs Nerv Syst 24:1447–1455PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing 2017

Authors and Affiliations

  1. 1.Division of Hematology/Oncology, Departments of PediatricsUniversity of California San Francisco & UCSF Benioff Children’s HospitalSan FranciscoUSA
  2. 2.Division of Hematology/Oncology, Departments of Pediatrics and Neurological SurgeryUniversity of California San Francisco & UCSF Benioff Children’s HospitalSan FranciscoUSA

Personalised recommendations